Analyst Ratings For NASDAQ:ARQL – ArQule (NASDAQ:ARQL)
Today, Oppenheimer initiated coverage on NASDAQ:ARQL – ArQule (NASDAQ:ARQL) with a Outperform with a price target of $7.00.
Some recent analyst ratings include
- 6/12/2018-Oppenheimer initiated coverage with a Outperform rating.
- 5/8/2018-Needham & Company LLC Reiterated Rating of Buy ➝ Buy.
- 4/5/2018-Leerink Swann Upgrade from a “Market Perform ➝ Outperform” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:ARQL – ArQule (NASDAQ:ARQL)
NASDAQ:ARQL – ArQule (NASDAQ:ARQL) has insider ownership of 7.90% and institutional ownership of 65.48%.
- On 5/30/2018 Value Fund L P Biotechnology, Insider, sold 1,035,939 with an average share price of $5.00 per share and the total transaction amounting to $5,179,695.00.
- On 5/18/2018 Paolo Pucci, CEO, bought 15,000 with an average share price of $3.39 per share and the total transaction amounting to $50,850.00.
- On 5/18/2018 Ran Nussbaum, Director, bought 8,611 with an average share price of $3.29 per share and the total transaction amounting to $28,330.19.
- On 5/14/2018 Patrick J Zenner, Director, bought 8,446 with an average share price of $2.96 per share and the total transaction amounting to $25,000.16.
- On 5/10/2018 Paolo Pucci, CEO, bought 1,300 with an average share price of $2.64 per share and the total transaction amounting to $3,432.00.
- On 5/10/2018 Ronald M Lindsay, Director, bought 23,900 with an average share price of $2.67 per share and the total transaction amounting to $63,813.00.
- On 4/18/2018 Value Fund L P Biotechnology, Insider, sold 2,230,373 with an average share price of $3.10 per share and the total transaction amounting to $6,914,156.30.
Recent Trading Activity for NASDAQ:ARQL – ArQule (NASDAQ:ARQL)
Shares of NASDAQ:ARQL – ArQule closed the previous trading session at 5.40 up +0.12 2.27% with 5.400000095367432 shares trading hands.